Bourla told CNN in an interview that Pfizer is still negotiating with the U.S. on whether it will be able to deliver the vaccine in the second or third quarter of the year.
Bourla told CNN in an interview that Pfizer is still negotiating with the U.S. on whether it will be able to deliver the vaccine in the second or third quarter of the year.